Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Key Takeaways on Wegovy Insurance Coverage FDA-approved for weight management : Wegovy (semaglutide 2.4mg) is approved for chronic weight management in adults with BMI 30, or BMI 27 with at least one weight-related comorbidity Commercial insurance coverage is expanding : About 40-50% of employer-sponsored plans now cover GLP-1 medications for weight loss, up from under 20% in 2023 Medicare does NOT cover Wegovy for weight loss : Federal law prohibits Medicare Part D from covering drugs prescribed solely for weight management no exceptions List price without insurance : Approximately $1,349/month ($16,188/year) at retail pharmacy Savings programs available : Novo Nordisk offers a savings card reducing cost to as low as $0-$25/month for eligible commercially insured patients Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk
Out-of-Stock Available Out-of-Stock Last items in stock Tap to zoom
GLP-1 keeps food in your stomach longer and tells the satiety centers in your brain to think about food less
My stomach is flat, and my scars are thin
GLP-1 drugs are generally safe but monitored
Approved anti-obesity medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: anti-obesity drugs in the sky and on the horizon
